Elicera Therapeutics AB (publ) (STO:ELIC)
Sweden · Delayed Price · Currency is SEK 5.60
+0.08 (1.45%)
Apr 10, 2026, 2:23 PM CET
Elicera Therapeutics AB Market Cap
Elicera Therapeutics AB has a market cap or net worth of 267.92 million as of April 10, 2026. Its market cap has increased by 130.96% in one year.
Market Cap
267.92M
Enterprise Value
243.07M
Revenue
10.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
5.60
Market Cap Chart
Since June 11, 2021, Elicera Therapeutics AB's market cap has increased from 122.65M to 267.92M, an increase of 118.44%. That is a compound annual growth rate of 17.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 267.92M | 5.75% |
| Dec 30, 2025 | 253.36M | 332.30% |
| Dec 30, 2024 | 58.61M | -35.03% |
| Dec 29, 2023 | 90.21M | 29.73% |
| Dec 30, 2022 | 69.53M | -29.98% |
| Dec 30, 2021 | 99.31M | -19.03% |
| Jun 11, 2021 | 122.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corline Biomedical AB | 414.94M |
| Ascelia Pharma AB | 367.92M |
| Bio-Works Technologies AB | 347.99M |
| Sprint Bioscience AB | 275.40M |
| Intervacc AB | 274.70M |
| Mendus AB | 261.96M |
| Diamyd Medical AB | 237.13M |
| Xintela AB | 221.35M |